Hypertension, Vol 21, 660-666, Copyright © 1993 by American Heart Association
DM Pollock, JS Polakowski, BJ Divish and TJ Opgenorth
Blockade of the renin-angiotensin system was studied in male Sprague-
Dawley rats during long-term inhibition of nitric oxide synthase. Nitro-
L-arginine-methyl ester (L-NAME) was placed in the drinking water for 4
weeks (approximately 100 mg/kg per day). Separate groups of rats were
coadministered the angiotensin II antagonist A-81988 in the drinking water
ranging from approximately 0.001 to 1 mg/kg per day. Control groups
received only tap water or A-81988 alone. Each week, rats were placed in
metabolic cages, and tail-cuff blood pressures and blood samples were
taken. L-NAME produced a sustained elevation in tail-cuff pressure that was
completely prevented by A-81988. No changes in creatinine clearance, sodium
excretion, plasma creatinine concentration, or blood urea nitrogen were
observed. Food and water intakes were identical in all groups. Water
excretion was significantly increased in L-NAME-treated animals regardless
of additional inhibitor treatment, suggesting a possible role for nitric
oxide synthase in the control of water excretion; this effect was
independent of blood pressure. Although less potent than A-81988, the
angiotensin II antagonist losartan and the angiotensin converting enzyme
inhibitor enalapril also blocked L-NAME-induced hypertension. In a separate
series of experiments, rats were not given A-81988 until 2 weeks after
hypertension had fully developed in L-NAME-treated rats. Within 1 week of
treatment with the angiotensin II antagonist, tail-cuff pressure returned
to normal. We conclude from these studies that long-term inhibition of
endogenous nitric oxide production produces an angiotensin II-dependent
form of hypertension.
ARTICLES
Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition
Abbott Laboratories, Abbott Park, IL 60064.
This article has been cited by other articles:
![]() |
H. Francois, N. Makhanova, P. Ruiz, J. Ellison, L. Mao, H. A. Rockman, and T. M. Coffman A role for the thromboxane receptor in L-NAME hypertension Am J Physiol Renal Physiol, October 1, 2008; 295(4): F1096 - F1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Vargas, J. M. Moreno, R. Wangensteen, I. Rodriguez-Gomez, and J. Garcia-Estan The endocrine system in chronic nitric oxide deficiency Eur. J. Endocrinol., January 1, 2007; 156(1): 1 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A Voors, P. P. van Geel, H. Buikema, M. Oosterga, D. J van Veldhuisen, and W. H van Gilst High Angiotensin II Responsiveness is Associated with Decreased Endothelium-Dependent Relaxation in Human Arteries Journal of Renin-Angiotensin-Aldosterone System, September 1, 2005; 6(3): 145 - 150. [Abstract] [PDF] |
||||
![]() |
G. L. Baumbach, C. D. Sigmund, and F. M. Faraci Structure of Cerebral Arterioles in Mice Deficient in Expression of the Gene for Endothelial Nitric Oxide Synthase Circ. Res., October 15, 2004; 95(8): 822 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Graciano, R. d. C. Cavaglieri, H. Delle, W. V. Dominguez, D. E. Casarini, D. M. A. C. Malheiros, and I. L. Noronha Intrarenal Renin-Angiotensin System Is Upregulated in Experimental Model of Progressive Renal Disease Induced by Chronic Inhibition of Nitric Oxide Synthesis J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1805 - 1815. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Fortepiani, M. C. O. Ruiz, F. Passardi, M. D. Bentley, J. Garcia-Estan, E. L. Ritman, and J. C. Romero Effect of losartan on renal microvasculature during chronic inhibition of nitric oxide visualized by micro-CT Am J Physiol Renal Physiol, November 1, 2003; 285(5): F852 - F860. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Reckelhoff and J. C. Romero Role of oxidative stress in angiotensin-induced hypertension Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R893 - R912. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Obst, V. Gross, J. Janke, M. Wellner, W. Schneider, and F. C. Luft Pressure Natriuresis in AT2 Receptor-Deficient Mice with L-NAME Hypertension J. Am. Soc. Nephrol., February 1, 2003; 14(2): 303 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yan, D. Kim, T. Aizawa, and B. C. Berk Functional Interplay Between Angiotensin II and Nitric Oxide: Cyclic GMP as a Key Mediator Arterioscler Thromb Vasc Biol, January 1, 2003; 23(1): 26 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Casellas, A. Herizi, A. Artuso, A. Mimran, and B. Jover Candesartan prevents L-NAME-induced cardio-renal injury in spontaneously hypertensive rats beyond hypotensive effects Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S84 - S90. [Abstract] [PDF] |
||||
![]() |
L. Raij Workshop: Hypertension and Cardiovascular Risk Factors : Role of the Angiotensin II-Nitric Oxide Interaction Hypertension, February 1, 2001; 37(2): 767 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. DE GRACIA, A. OSUNA, F. O'VALLE, R. G. DEL MORAL, R. WANGENSTEEN, C. G. DEL RIO, and F. VARGAS Deoxycorticosterone Suppresses the Effects of Losartan in Nitric Oxide--Deficient Hypertensive Rats J. Am. Soc. Nephrol., November 1, 2000; 11(11): 1995 - 2000. [Abstract] [Full Text] |
||||
![]() |
M. KASHIWAGI, M. SHINOZAKI, H. HIRAKATA, K. TAMAKI, T. HIRANO, M. TOKUMOTO, H. GOTO, S. OKUDA, and M. FUJISHIMA Locally Activated Renin-Angiotensin System Associated with TGF-{beta}1 as a Major Factor for Renal Injury Induced by Chronic Inhibition of Nitric Oxide Synthase in Rats J. Am. Soc. Nephrol., April 1, 2000; 11(4): 616 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Alvarez, A. Osuna, R. Wangensteen, and F. Vargas Interaction Between Nitric Oxide and Mineralocorticoids in the Long-Term Control of Blood Pressure Hypertension, March 1, 2000; 35(3): 752 - 757. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Loichot, C. Cazaubon, M. Grima, W. De Jong, D. Nisato, J.-L. Imbs, and M. Barthelmebs Vasopressin Does not Effect Hypertension Caused by Long-Term Nitric Oxide Inhibition Hypertension, February 1, 2000; 35(2): 602 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Bergamaschi, R. R. Campos, and O. U. Lopes Rostral Ventrolateral Medulla : A Source of Sympathetic Activation in Rats Subjected to Long-Term Treatment With L-NAME Hypertension, October 1, 1999; 34(4): 744 - 747. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Riado, A. Zanesco, L. A. Barker, I. M. S. De Luca, E. Antunes, and G. De Nucci Long-Term Nitric Oxide Inhibition and Chronotropic Responses in Rat Isolated Right Atria Hypertension, October 1, 1999; 34(4): 802 - 807. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Rudd, M. Trolliet, S. Hope, A. W. Scribner, G. Daumerie, G. Toolan, T. Cloutier, and J. Loscalzo Salt-induced hypertension in Dahl salt-resistant and salt-sensitive rats with NOS II inhibition Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H732 - H739. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kalliovalkama, P. Jolma, J.-P. Tolvanen, M. Kahonen, N. Hutri-Kahonen, X. Wu, P. Holm, and I. Porsti Arterial function in nitric oxide-deficient hypertension: influence of long-term angiotensin II receptor antagonism Cardiovasc Res, June 1, 1999; 42(3): 773 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. FORTEPIANI, E. RODRIGO, M. C. ORTÍZ, V. CACHOFEIRO, N. M. ATUCHA, L. M. RUILOPE, V. LAHERA, and J. GARCÍA-ESTAÑ Pressure Natriuresis in Nitric Oxide-Deficient Hypertensive Rats: Effect of Antihypertensive Treatments J. Am. Soc. Nephrol., January 1, 1999; 10(1): 21 - 27. [Abstract] [Full Text] |
||||
![]() |
A. Kurtz and C. Wagner Role of nitric oxide in the control of renin secretion Am J Physiol Renal Physiol, December 1, 1998; 275(6): F849 - F862. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zatz and C. Baylis Chronic Nitric Oxide Inhibition Model Six Years On Hypertension, December 1, 1998; 32(6): 958 - 964. [Full Text] [PDF] |
||||
![]() |
D. M. Pollock and A. Rekito Hypertensive response to chronic NO synthase inhibition is different in Sprague-Dawley rats from two suppliers Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1998; 275(5): R1719 - R1723. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Luvara, M. E. Pueyo, M. Philippe, C. Mandet, F. Savoie, D. Henrion, and J.-B. Michel Chronic Blockade of NO Synthase Activity Induces a Proinflammatory Phenotype in the Arterial Wall : Prevention by Angiotensin II Antagonism Arterioscler Thromb Vasc Biol, September 1, 1998; 18(9): 1408 - 1416. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Usui, T. Ichiki, M. Katoh, K. Egashira, and A. Takeshita Regulation of Angiotensin II Receptor Expression by Nitric Oxide in Rat Adrenal Gland Hypertension, September 1, 1998; 32(3): 527 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Gonzalez, M. T. Llinas, E. Nava, L. Ghiadoni, and F. J. Salazar Role of Nitric Oxide and Prostaglandins in the Long-term Control of Renal Function Hypertension, July 1, 1998; 32(1): 33 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Ortiz, L. A. Fortepiani, F. M. Ruiz-Marcos, N. M. Atucha, and J. Garcia-Estan Role of AT1 receptors in the renal papillary effects of acute and chronic nitric oxide inhibition Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R760 - R766. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Qiu, D. Muchant, W. H. Beierwaltes, L. Racusen, and C. Baylis Evolution of Chronic Nitric Oxide Inhibition Hypertension: Relationship to Renal Function Hypertension, January 1, 1998; 31(1): 21 - 26. [Abstract] [Full Text] |
||||
![]() |
P. Madeddu, M. V. Varoni, D. Palomba, C. Emanueli, M. P. Demontis, N. Glorioso, P. Dessi-Fulgheri, R. Sarzani, and V. Anania Cardiovascular Phenotype of a Mouse Strain With Disruption of Bradykinin B2-Receptor Gene Circulation, November 18, 1997; 96(10): 3570 - 3578. [Abstract] [Full Text] |
||||
![]() |
M. I. Madrid, M. Garcia-Salom, J. Tornel, M. De Gasparo, and F. J. Fenoy Effect of interactions between nitric oxide and angiotensin II on pressure diuresis and natriuresis Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1997; 273(5): R1676 - R1682. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Chillon, S. Ghoneim, and G. L. Baumbach Effects of Chronic Nitric Oxide Synthase Inhibition on Cerebral Arterioles in Rats Hypertension, November 1, 1997; 30(5): 1097 - 1104. [Abstract] [Full Text] |
||||
![]() |
M. I. Madrid, M. Garcia-Salom, J. Tornel, M. de Gasparo, and F. J. Fenoy Interactions Between Nitric Oxide and Angiotensin II on Renal Cortical and Papillary Blood Flow Hypertension, November 1, 1997; 30(5): 1175 - 1182. [Abstract] [Full Text] |
||||
![]() |
A. Montanari, E. Tateo, E. Fasoli, D. Giberti, P. Perinotto, A. Novarini, and P. Dall'Aglio Angiotensin II Blockade Does Not Prevent Renal Effects of L-NAME in Sodium-Repleted Humans Hypertension, September 1, 1997; 30(3): 557 - 562. [Abstract] [Full Text] |
||||
![]() |
P. R. Knoblich, R. H. Freeman, and D. Villarreal Pressure-Dependent Renin Release During Chronic Blockade of Nitric Oxide Synthase Hypertension, November 1, 1996; 28(5): 738 - 742. [Abstract] [Full Text] |
||||
![]() |
D. Henrion, F. J. Dowell, B. I. Levy, and J.-B. Michel In Vitro Alteration of Aortic Vascular Reactivity in Hypertension Induced by Chronic NG-Nitro-L-Arginine Methyl Ester Hypertension, September 1, 1996; 28(3): 361 - 366. [Abstract] [Full Text] |
||||
![]() |
M. E. Ullian, D. J. Hazen-Martin, L. G. Walsh, R. K. Davda, and B. M. Egan Carbenoxolone Damages Endothelium and Enhances Vasoconstrictor Action in Aortic Rings Hypertension, June 1, 1996; 27(6): 1346 - 1352. [Abstract] [Full Text] |
||||
![]() |
S. S. Yamada, A. L. Sassaki, C. K. Fujihara, D. M. Avancini Costa Malheiros, G. De Nucci, and R. Zatz Effect of Salt Intake and Inhibitor Dose on Arterial Hypertension and Renal Injury Induced by Chronic Nitric Oxide Blockade Hypertension, May 1, 1996; 27(5): 1165 - 1172. [Abstract] [Full Text] |
||||
![]() |
N. Bouriquet, M. Dupont, A. Herizi, A. Mimran, and D. Casellas Preglomerular Sudanophilia in L-NAME Hypertensive Rats : Involvement of Endothelin Hypertension, March 1, 1996; 27(3): 382 - 391. [Abstract] [Full Text] |
||||
![]() |
D. L. Mattson and D. J. Higgins Influence of Dietary Sodium Intake on Renal Medullary Nitric Oxide Synthase Hypertension, March 1, 1996; 27(3): 688 - 692. [Abstract] [Full Text] |
||||
![]() |
H. Ono, Y. Ono, and E. D. Frohlich ACE Inhibition Prevents and Reverses L-NAMEExacerbated Nephrosclerosis in Spontaneously Hypertensive Rats Hypertension, February 1, 1996; 27(2): 176 - 183. [Abstract] [Full Text] |
||||
![]() |
H. Guan, V. Cachofeiro, M. L. Pucci, P. M. Kaminski, M. S. Wolin, and A. Nasjletti Nitric Oxide and the Depressor Response to Angiotensin Blockade in Hypertension Hypertension, January 1, 1996; 27(1): 19 - 24. [Abstract] [Full Text] |
||||
![]() |
H. Takase, P. Moreau, C. F. Kung, E. Nava, and T. F. Luscher Antihypertensive Therapy Prevents Endothelial Dysfunction in Chronic Nitric Oxide Deficiency : Effect of Verapamil and Trandolapril Hypertension, January 1, 1996; 27(1): 25 - 31. [Abstract] [Full Text] |
||||
![]() |
K. Numaguchi, K. Egashira, M. Takemoto, T. Kadokami, H. Shimokawa, K. Sueishi, and A. Takeshita Chronic Inhibition of Nitric Oxide Synthesis Causes Coronary Microvascular Remodeling in Rats Hypertension, December 1, 1995; 26(6): 957 - 962. [Abstract] [Full Text] |
||||
![]() |
P. Moreau, H. Takase, C. F. Kung, M.-M. van Rooijen, T. Schaffner, and T. F. Luscher Structure and Function of the Rat Basilar Artery During Chronic Nitric Oxide Synthase Inhibition Stroke, October 1, 1995; 26(10): 1922 - 1929. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |